Novartis AG NVS launched topline outcomes from the interim evaluation...
Disease
Takeda Pharmaceutical Co Ltd TAK launched topline information from the...
Akero Therapeutics Inc AKRO reported a 36-week evaluation of SYMMETRY,...
Pliant Therapeutics Inc PLRX introduced information from the INTEGRIS-PSC Part...